Cardiovascular implantable electronic devices in athletes

Cardiovascular Therapeutics

Volumn 28, Issue 5, 2010, Pages 327-336

  Do, Rose ^a   Patton, Kristen K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Athlete; Cardiac devices; Implantable cardioverter defibrillator; Pacemaker

Indexed keywords

ARTIFICIAL HEART PACEMAKER; ATHLETE; CARDIOVASCULAR DISEASE; DEFIBRILLATOR; DEVICE; HEART DEATH; HUMAN; IMPLANTATION; PHYSICAL ACTIVITY; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; ATHLETES; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; HUMANS; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 77956429854     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00162.x     Document Type: Review

References (53)

1. Proclemer A, Ghidina M, Facchin D, et al. Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: Data from Italian ICD Registry for the years 2001-6. Pacing Clin Electrophysiol 2009 32 : 434 445.
2. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003 42 : 1959 1963.
3. Drezner J, Courson R, Roberts W, Mosesso VJ, Link M, Maron B. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: A consensus statement. Clin J Sport Med 2007 17 : 87 103. (Pubitemid 46603631)
4. Zipes DP, Ackerman MJ, Estes I, Mark NA, Grant AO, Myerburg RJ, Van Hare G. 36th Bethesda Conference Eligibility Recommendations For Competitive Athletes with Cardiovascular Abnormalities. Task Force 7: Arrhythmias. J Am College Cardiol 54 : 1354 1363.
5. Maron B, Zipes D. Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 2005 45 : 1318 1321.
6. Maron BJ, Zipes DP. 36th Bethesda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am College Cardiol 2005 45 : 2 64.
7. Maron B, Chaitman B, Ackerman M, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004 109 : 2807 2816.
8. Pelliccia A, Zipes D, Maron B. Bethesda Conference 36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008 52 : 1990 1996.
9. Maron B, Mitten M, Quandt E, Zipes D. Competitive athletes with cardiovascular disease-the case of Nicholas Knapp. N Engl J Med 1998 339 : 1632 1635.
10. Heidbüchel H, Corrado D, Biffi A, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 2006 13 : 676 686. (Pubitemid 44462668)
11. Heidbüchel H, Panhuyzen-Goedkoop N, Corrado D, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006 13 : 475 484. (Pubitemid 44164254)
12. Klossner D. 2008-2009 NCAA sports medicine handbook. Overland Park: NCAA, 2008 1 126.
13. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: A survey of heart rhythm society members. J Cardiovasc Electrophysiol 2006 17 : 11 15.
14. Proclemer A, Ghidina M, Gregori D, et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: Data from the Italian ICD Registry for the years 2005-07. Europace 2009 11 : 465 475.
15. Mitten M, Maron B, Zipes D. Task Force 12: Legal aspects of the 36th Bethesda Conference recommendations. J Am Coll Cardiol 2005 45 : 1373 1375.
16. Hassmén P, Koivula N, Uutela A. Physical exercise and psychological well-being: A population study in Finland. Prev Med 2000 30 : 17 25.
17. Albert C, Mittleman M, Chae C, Lee I, Hennekens C, Manson J. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000 343 : 1355 1361.
18. Fuerst M. Gilbert Mudge cleared of charges in death of Boston Celtics' Reggie Lewis. The Heart. Available from : http://www.theheart.org/article/ 199839.do Assessed 9 May 2009
19. MV, Daubert JP. Risks and challenges of implantable cardioverter- defibrillators in young adults. Prog Cardiovasc Dis 2008 51 : 237 263.
20. Borek P, Wilkoff B. Pacemaker and ICD leads: Strategies for long-term management. J Interv Card Electrophysiol 2008 23 : 59 72.
21. Klug D, Vaksmann G, Jarwé M, et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol 2003 26 : 1489 1493.
22. Heidbüchel H. Implantable cardioverter defibrillator therapy in athletes. Cardiol Clin 2007 25 : 467 482.
23. Estes Nr, Link M, Cannom D, et al. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol 2001 12 : 1208 1219.
24. Lamas G, Keefe J. The effects of equitation (horseback riding) on a motion responsive DDDR pacemaker. Pacing Clin Electrophysiol 1990 13 : 1371 1373.
25. DiMarco J. Athletes and arrhythmias: Welcome new guidelines. J Cardiovasc Electrophysiol 2001 12 : 1220 1221.
26. Mitchell J, Haskell W, Snell P, Van Camp S. Task Force 8: Classification of sports. J Am Coll Cardiol 2005 45 : 1364 1367.
27. Lampert R, Jain D, Burg M, Batsford W, McPherson C. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation 2000 101 : 158 164.
28. Drezner J, Pluim B, Engebretsen L. Prevention of sudden cardiac death in athletes: New data and modern perspectives confront challenges in the 21st century. Br J Sports Med 2009 43 : 625 626.
29. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002 40 : 446 452.
30. Link M. Prevention of sudden cardiac death: Return to sport considerations in athletes with identified cardiovascular abnormalities. Br J Sports Med 2009 43 : 685 689.
31. Fries R, König J, Schäfers H, Böhm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol 2002 25 : 474 478.
32. Lampert R, Joska T, Burg M, Batsford W, McPherson C, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002 106 : 1800 1805.
33. Medscape CRM. Driving and moderate exertion studied as triggers of VT/VF leading to ICD Discharge. Medscape CRM News. Available from : http://www.medscape.com/viewarticle/465476 Assessed 11 Dec 2003
34. B Zipes D, It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports. Heart Rhythm 2008 5: 864-866.
35. Suddath W, Deychak Y, Varghese P. Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. Ann Emerg Med 2001 38 : 201 206.
36. Pharand C, Goldman R, Fan C, Chow M, Kluger J. Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds. Pacing Clin Electrophysiol 1996 19 : 82 89.
37. Sousa J, Kou W, Calkins H, Rosenheck S, Kadish A, Morady F. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 1992 69 : 509 512.
38. Kalus J, White C, Caron M, Guertin D, McBride B, Kluger J. The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillators. Pacing Clin Electrophysiol 2005 28 : 1147 1156.
39. Begley D, Mohiddin S, Tripodi D, Winkler J, Fananapazir L. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003 26 : 1887 1896.
40. Pinski S, Fahy G. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995 92 : 1651 1664.
41. Veltmann C, Kuschyk J, Schimpf R, Streitner F, Schoene N, Borggrefe M, Wolpert C. Prevention of inappropriate ICD shocks in patients with Brugada syndrome. Clin Res Cardiol 2010 99 : 37 44.
42. Hai A, Kalinchak D, Schoenfeld M. Increased defibrillator charge time following direct trauma to an ICD generator: Blunt consequences. Pacing Clin Electrophysiol 2009 32 : 1587 1590.
43. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004 109 : 2807 2816.
44. Cesario D, Dec G. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 2006 47 : 1507 1517.
45. Seggewiss H, Blank C, Pfeiffer B, Rigopoulos A. Hypertrophic cardiomyopathy as a cause of sudden death. Herz 2009 34 : 305 314.
46. Futterman LG, Lemberg L. Sudden death in athletes. Am J Crit Care 1995 4 : 239 243.
47. Hebbar A, Hueston W. Management of common arrhythmias: Part II. Ventricular arrhythmias and arrhythmias in special populations. Am Fam Physician 2002 65 : 2491 2496.
48. Hebbar A, Hueston W. Management of common arrhythmias: Part I. Supraventricular arrhythmias. Am Fam Physician 2002 65 : 2479 2486.
49. Elliott C. In defense of the beta blocker. The Atlantic. Available from : http://www.theatlantic.com/magazine/archive/2008/08/in-defense-of-the-beta- blocker/6961/ Assessed 20 Aug 2008 DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006 48 : e247 e346.
50. Kauferstein S, Kiehne N, Neumann T, Pitschner H, Bratzke H. Cardiac gene defects can cause sudden cardiac death in young people. Dtsch Arztebl Int 2009 106 : 41 47.
51. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988 318 : 129 133.
52. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009 119 : 1085 1092.
53. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000 94 : 99 102.